LifeMD Podcast
LifeMD Podcast
Podcast Description
More than 40% of adults in the US struggle with obesity, a chronic disease that's linked to more than 200 comorbidities. Fortunately, breakthrough medications called GLP-1s are helping millions of people lose weight and improve their health, and the leading telehealth company, Life MD, is leading the charge.
It's lauded weight management program combines these groundbreaking medications with personalized treatment plans and ongoing clinical support. Today, we are joined by Dr. Banita Sehgal, a prescribing physician for Life MD and an expert in sustainable weight management.
Podcast Insights
Content Themes
The podcast focuses on weight management, chronic disease prevention, and breakthrough medical treatments with episodes covering topics like the impact of GLP-1 medications on obesity and success stories from patients who have transformed their health through the LifeMD program, alongside discussions around lifestyle changes and sustainable health practices.
More than 40% of adults in the US struggle with obesity, a chronic disease that’s linked to more than 200 comorbidities. Fortunately, breakthrough medications called GLP-1s are helping millions of people lose weight and improve their health, and the leading telehealth company, Life MD, is leading the charge.
It’s lauded weight management program combines these groundbreaking medications with personalized treatment plans and ongoing clinical support. Today, we are joined by Dr. Banita Sehgal, a prescribing physician for Life MD and an expert in sustainable weight management.
LifeMD Podcast
Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.